Translations by: The LUMC team, particularly Frans van Nieuwpoort
Publications
Pastorino L, Cusano R, Nasti S, Faravelli F, Forzano F, Barile M, Gliori S, Muggianu M, Ghigliotti G, Lacaita MG, Lo Muzio L, Bianchi-Scarra’ G Molecular characterization of Italian Nevoid Basal Cell Carcinoma Syndrome patients. Hum Mutat. accepted
Mantelli M, Pastorino L, Ghiorzo P, Barile M, Bruno W, Gargiulo S, Sormani MP, Gliori S, Vecchio S, Ciotti P, Sertoli MR, Queirolo P, the Italian Melanoma Intergroup, Goldstein AM and Bianchi Scarrà G. Early onset may predict G101W CDKN2A founder mutation carrier status in Ligurian melanoma patients. Melanoma Res 2004 in press
Pastorino L, Cusano R, Bruno W, Lantieri F, Origone P, Barile M, Gliori S, Shepherd GA, Sturm RA, Bianchi-Scarra G. Novel MC1R variants in Ligurian melanoma patients and controls. Hum Mutat. 2004 Sep;24(3):274.
Ghiorzo P, Villaggio B, Sementa AR, Hansson J, Platz A, Nicolo G, Spina B, Canepa M, Palmer JM, Hayward NK, Bianchi-Scarra G. Expression and localization of mutant p16 proteins in melanocytic lesions from familial melanoma patients. Hum Pathol. 2004 Jan;35(1):25-33.
Casula M, Colombino M, Satta MP, Cossu A, Ascierto PA, Bianchi-Scarra G, Castiglia D, Budroni M, Rozzo C, Manca A, Lissia A, Carboni A, Petretto E, Satriano SM, Botti G, Mantelli M, Ghiorzo P, Stratton MR, Tanda F, Palmieri G;Italian Melanoma Intergroup Study.
BRAF gene is somatically mutated but does not make a major contribution to malignant melanoma susceptibility: the Italian Melanoma Intergroup Study. J Clin Oncol. 2004 Jan 15;22(2):286-92
Bianchi-ScarràG, Testori A and Mihm M. What is new in melanoma research: genetics and epidemiology of melanoma in 2003? Review of a workshop held in Milan in May 2003. Melanoma Res. Apr;14(2):77-84. 2004
Mantelli M, Barile M, Ciotti P, Ghiorzo P, Lantieri F, Pastorino L, Catricala C, Torre GD, Folco U, Grammatico P, Padovani L, Pasini B, Rovini D, Queirolo P, Rainero ML, Santi PL, Sertoli RM, Goldstein AM, Bianchi-Scarra G; Societa Italiana Dermatologia; Gruppo Italiano Studi Epidemiologici in Dermatologia. High prevalence of the G101W germline mutation in the CDKN2A (P16(ink4a)) gene in 62 Italian malignant melanoma families. Am J Med Genet. 2002 Jan 22;107(3):214-21.
Bishop DT, Demenais F, Goldstein AM, Bergman W, Bishop JN, Bressac-de Paillerets B, Chompret A, Ghiorzo P, Gruis N, Hansson J, Harland M, Hayward N,Holland EA, Mann GJ, Mantelli M, Nancarrow D, Platz A, Tucker MA; Melanoma Genetics Consortium.
Geographical variation in the penetrance of CDKN2A mutations for melanoma. J Natl Cancer Inst. 2002,94:894-903.
Ciotti P, Van Dyke MW, Bianchi-Scarra G, Musso M. Characterization of a triplex DNA-binding protein encoded by an alternative reading frame of loricrin. Eur J Biochem. 2001 Jan;268(2):225-34.
Ciotti P, Struewing JP, Mantelli M, Chompret A, Avril MF, Santi PL, Tucker MA, Bianchi-Scarra G, Bressac-de Paillerets B, Goldstein AM. A single genetic origin for the G101W CDKN2A mutation in 20 melanoma-prone families. Am J Hum Genet. 2000 Aug;67(2):311-9. Epub 2000 Jun 22
Ghiorzo P, Ciotti P, Mantelli M, Heouaine A, Queirolo P, Rainero ML, Ferrari C, Santi PL, De Marchi R, Farris A, Ajmar F, Bruzzi P, Bianchi-Scarra G. Characterization of Ligurian melanoma families and risk of occurrence of other neoplasia. Int J Cancer. 1999 Nov 12;83(4):441-8.
